You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)


✉ Email this page to a colleague

« Back to Dashboard


MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)

Docket ⤷  Sign Up Date Filed 2023-05-18
Court District Court, W.D. Pennsylvania Date Terminated
Cause 15:2 Antitrust Litigation Assigned To Mark Raymond Hornak
Jury Demand Plaintiff Referred To
Patents 7,476,652; 7,713,930; 7,918,833; 8,512,297; 8,556,864; 8,603,044; 8,679,069; 8,992,486; 9,011,391; 9,233,211; 9,408,979; 9,526,844; 9,533,105; 9,561,331; 9,604,008; 9,604,009; 9,610,409; 9,623,189; 9,717,852; 9,775,954; 9,827,379
Link to Docket External link to docket
Small Molecule Drugs cited in MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC
The small molecule drug covered by the patents cited in this case is ⤷  Sign Up .
Biologic Drugs cited in MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for MYLAN PHARMACEUTICALS INC. v. SANOFI-AVENTIS U.S. LLC (W.D. Pa. 2023)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 External link to document
2023-05-17 1 Complaint (for Clerk of Court personnel only) January 13, 2009, the PTO issued U.S. Patent No. 7,476,652 (“the ’652 patent”), entitled “Acidic Insulin Preparations… First Notice Letter Patents 7,476,652 Acidic Insulin Determined…reality, the only patents plausibly listed properly in the Orange Book were the 7,476,652 and 7,713,930… First Notice Letter Patents 7,476,652 Acidic Insulin Determined…ingredient) patents, drug product (formulation and composition) patents, and method of use patents.” Abbreviated External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.